Elie Haddad, MD, PhD, M.D

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

• Severe combined immunodeficiency due to adenosine deaminase deficiency→
• Primary immunodeficiency→

Clinical trials (2)

• NCT01420627
• NCT01346150

Verify independently

• ClinicalTrials.gov PI search for Elie Haddad, MD, PhD
• NPPES NPI registry entry

Other specialists for Severe combined immunodeficiency due to adenosine deaminase deficiency

Peers ranked by clinical-trial PI role, publications, and verification quality.

• Donald B. Kohn, MD, D.D.S
  University of California, Los Angeles
  CT
• Donald B Kohn, MD, D.D.S
  University of California, Los Angeles
  CT
• Joel Moss, M.D.
  National Heart, Lung, and Blood Institute (NHLBI)
  Maryland
• Lung-Ji Chang, Ph.D
  Shenzhen Geno-Immune Medical Institute
  Guangdong
• Claire Booth, Dr
  Great Ormond Street Hospital NHS Foundation Trust
• Donald B. Kohn, M.D., D.D.S
  University of California, Los Angeles
  CT
• Elizabeth K Garabedian, R.N.
  National Human Genome Research Institute (NHGRI)
• Lauri Burroughs
  Fred Hutch/University of Washington Cancer Consortium
  Washington

See all specialists for Severe combined immunodeficiency due to adenosine deaminase deficiency →